Catherine Alix-Panabières, Director of the Laboratory of Rare Human Circulating Cells and Professor of Universities – Hospital Practitioner at Montpellier University Hospital, shared a post on LinkedIn:
“It was a pleasure and an honor to be invited to speak at the 2nd Scientific Day on Liquid Biopsy in Paris and to share our latest findings on ctDNA — and beyond “CTCs, EVs, CirculatingImmuneCells, Proteins etc.
The Future? The multi-omics
A wonderful venue, inspiring presentations, and stimulating discussions on the future of liquid biopsy in oncology.
A sincere thank you to the Scientific Committee for the invitation, and especially to Etienne Rouleau, Marie Morfouace, Christophe Le Tourneau, and Nathalie Lassau, with whom I had the opportunity to exchange in person.
The French liquid biopsy community is a true force in this field and one that should not be underestimated. By working together, we can continue to push the boundaries of precision oncology, accelerate innovation, and ultimately improve patient care.
Looking forward to the next steps and future collaborations. Let’s keep moving forward together!”
Other articles featuring Catherine Alix-Panabières.
